(Q35183032)

7 August 2017

1 reference

title

Surgery in metastatic testicular cancer (English)

1 reference

7 August 2017

Peter Albers

1

1 reference

7 August 2017

Diethild Melchior

series ordinal

2

1 reference

7 August 2017

Stefan C Müller

series ordinal

3

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

7 August 2017

1 reference

7 August 2017

volume

44

1 reference

7 August 2017

issue

2

1 reference

7 August 2017

page(s)

233-244

1 reference

Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: recommendations for patient selection

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900252-5

7 January 2021

Prognostic factors in unselected patients with nonseminomatous metastatic testicular cancer: a multicenter experience

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900252-5

7 January 2021

Is postchemotherapy retroperitoneal surgery necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses?

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900252-5

7 January 2021

Decision analysis for avoiding postchemotherapy surgery in patients with disseminated nonseminomatous germ cell tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900252-5

7 January 2021

The growing teratoma syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900252-5

7 January 2021

Persistent cancer in postchemotherapy retroperitoneal lymph-node dissection: outcome analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900252-5

7 January 2021

Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: prognostic factors and role of postsurgery chemotherapy--results from an international study group.

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900252-5

7 January 2021

Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groups

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900252-5

7 January 2021

Prediction models for the histology of residual masses after chemotherapy for metastatic testicular cancer. ReHiT Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900252-5

7 January 2021

Surgical resection in patients with nonseminomatous germ cell tumor who fail to normalize serum tumor markers after chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900252-5

7 January 2021

Surgical salvage of chemorefractory germ cell tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900252-5

7 January 2021

Surgery as salvage therapy in chemotherapy-resistant nonseminomatous germ cell tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900252-5

7 January 2021

Surgical resection of solitary metastases after chemotherapy in patients with nonseminomatous germ cell tumors and elevated serum tumor markers

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900252-5

7 January 2021

Late relapse of testicular cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900252-5

7 January 2021

Late relapse of germ cell tumors after cisplatin-based chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900252-5

7 January 2021

Advanced seminoma: the role of chemotherapy and adjunctive surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900252-5

7 January 2021

Management of postchemotherapy residual mass in patients with advanced seminoma: Indiana University experience

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900252-5

7 January 2021

Predictive impact of 2-18fluoro-2-deoxy-D-glucose positron emission tomography for residual postchemotherapy masses in patients with bulky seminoma

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900252-5

7 January 2021

Residual masses after chemotherapy for metastatic testicular cancer: the clinical implications of the association between retroperitoneal and pulmonary histology. Re-analysis of Histology in Testicular Cancer (ReHiT) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900252-5

7 January 2021

Sequential resection of residual abdominal and thoracic masses after chemotherapy for metastatic non-seminomatous germ cell tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900252-5

7 January 2021

Cisplatin-associated anaemia in patients with solid tumours. A retrospective evaluation and considerations relative to erythropoietin administration

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900252-5

7 January 2021

Erythropoietin in urologic oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900252-5

7 January 2021

Spinal cord ischemia after post-chemotherapy retroperitoneal lymph node dissection for nonseminomatous germ cell cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900252-5

7 January 2021

Vascular considerations in postchemotherapy. Retroperitoneal lymph-node dissection: Part II

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900252-5

7 January 2021

Vena caval resection in bulky metastatic germ cell tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900252-5

7 January 2021

Long-term results after inferior vena caval resection during retroperitoneal lymphadenectomy for metastatic germ cell cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900252-5

7 January 2021

Vascular interventions during post-chemotherapy retroperitoneal lymph-node dissection for metastatic testis cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900252-5

7 January 2021

Vascular considerations in postchemotherapy. Retroperitoneal lymph-node dissection: Part I--Vena cava

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900252-5

7 January 2021

Unusual thoracoabdominal sites of metastases in testicular tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900252-5

7 January 2021

Metastatic testicular tumor requiring inferior vena cava resection

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900252-5

7 January 2021

Vena caval resection for bulky metastatic germ cell tumors: an 18-year experience

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900252-5

7 January 2021

Wedge resection of pulmonary metastases from cancer of the testis or kidney using a vascular staple device

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900252-5

7 January 2021

Hepatic resection for disseminated germ cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900252-5

7 January 2021

Complications of retroperitoneal lymph node dissection

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900252-5

7 January 2021

Complications of thoracoabdominal retroperitoneal lymph node dissection

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900252-5

7 January 2021

Perioperative Considerations for Patients Treated with Bleomycin

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900252-5

7 January 2021

Management of chylous ascites after retroperitoneal lymph node dissection for testicular cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900252-5

7 January 2021

10.1016/S0302-2838(03)00252-5

Identifiers

DOI

1 reference

7 August 2017

1 reference